Asian Spectator

Men's Weekly

.

TrialWire launches StudyBoost, the Clinical Trial Insurance Plan

  • Written by ACN Newswire - Press Releases

TrialWire launches StudyBoost, the Clinical Trial Insurance Plan

SYDNEY & SAN FRANCISCO, Mar 23, 2021 - (ACN Newswire) - TrialWire(TM), the most secure digital Patient Recruitment Platform for trial rescue, announces the launch of StudyBoost, the monthly insurance plan that provides an instant patient recruitment boost at any time, across one or all sites depending on recruitment needs.

TrialWire launches StudyBoost, the Clinical Trial Insurance Plan

TrialWire, the algorithm powered recruitment platform, launches a Clinical Trial recruitment 'Insurance' plan. (3/2021)

With more than 80% of clinical trials failing to recruit patients on time, 30% of research sites not able to meet enrollment goals, and 10% of sites not able to enroll any patients, StudyBoost offers peace of mind for Clinical Directors and their CROs.

StudyBoost was designed so that sponsors avoid a trial rescue crisis, saving valuable time and money. If a study needs extra patients, StudyBoost can start delivering instantly and at a significantly reduced cost to normal recruitment. There are no project fees and there is a 50% fee reduction for enrolled patient success.

StudyBoost is ideal for sponsors and CROs wanting to avoid extended recruitment stalls while they find a recruitment firm and process engagement documentation which can take weeks. Which means a study has a recruitment booster plan ready to action at any time recruitment slows.

The package is only available from the start of a study. StudyBoost is available via the TrialWire(TM) self-serve portal, at https://www.trial-wire.com/studyboost/.

About TrialWire(TM) - www.trial-wire.com

The TrialWire(TM) Platform is the most secure service, using advanced algorithms to find the right people who are online that might be suitable for studies listed on the Platform. They are invited into the Platform and taken through the AI-Match screener to determine an exact match to a study-site based or remote/virtual.

No account sign-up is required to find and apply for a study. And unlike all other digital recruitment firms, TrialWire(TM) does NOT keep patient details - no databases so no potential privacy breaches. Sponsors are not paying for database building where patients are sent to other studies.

The Platform ingests study data from approved trial registries like ClinicalTrials.Gov. It uses advanced algorithms, SEO, search marketing, social media, respected news sites, and wellness blogs and more to find patient/trial matches. The algorithms find people based on detailed demographic and location profiles.

Key to TrialWire(TM) success is that it finds motivated people who are online actively trying to find out more about their conditions. These people can be connected to a site in under 2 minutes, and demonstrate the highest retention rates. Find out more about TrialWire at: https://www.trial-wire.com.

Contact:Sydney NSW AUS HQ, +61 2 8218 2145Singapore APAC HQ, +65 3159 3427San Francisco USA HQ, +1 415 951 3228E: team@trial-wire.com, www.trial-wire.com

Copyright 2021 ACN Newswire. All rights reserved. www.acnnewswire.com

Authors: ACN Newswire - Press Releases

Read more //?#

Magazine

Aksi boikot Israel: 5 dukungan yang bisa pemerintah lakukan alih-alih buka hubungan diplomatik

● Tanpa hubungan diplomatik, ekspor-impor Indonesia-Israel tetap tumbuh di tengah serangan ke Gaza.● Aksi boikot masyarakat berjalan tanpa dukungan negara. ● BDS bisa jadi strategi d...

Memilih menjadi lajang? Simak 5 tip ini untuk terus berkembang

Memasuki usia 20-30 tahun, banyak dari kita yang memasuki proses pencarian identitas dan membangun kehidupan sebagai orang dewasa. Tentunya lingkungan punya ekspektasi khusus untuk kita: menemukan cin...

Tips membangun rumah nyaman hemat energi, tanpa AC dan minim lampu

● Desain rumah ramah lingkungan bisa mengurangi konsumsi energi secara signifikan.● Cahaya matahari dan aliran udara optimal dapat membuat rumah di iklim tropis seperti Indonesia tetap nya...